Amendment #002-Mammalian Bioreactor Control System – Brand Name or Equal
Closed Solicitation Posted
- Solicitation number
- RFQ-NIAID-23-2177803
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Place of performance
- United States
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institute of Allergy and Infectious Diseases is seeking to procure mammalian bioreactor control systems and associated controller instruments to support vaccine development programs at its Gaithersburg, Maryland facility. The solicitation requires the supply of two dual controllers for 3L perfusion bioreactors, two dual controllers for 15L bioreactors, and ten dual controllers for 3L bioreactors. The control systems must support simultaneous operation of two bioreactor vessels, enable day-of gas flow configuration, and integrate with the agency's existing hardware, network, and Lucullus software. Quotes are due by September 27, 2023 and will be evaluated based on technical acceptability, price, and past performance, with price as a key discriminator for technically equivalent submissions.
There is no set-aside designation. The estimated period of performance is 180 days for delivery following award. The place of performance is within the United States. Potential incumbents for the requirement include Getinge Applikon, though equal products will be considered. The estimated total value across all contract line items is unknown, though individual dual controller prices may range from low five-figures to mid six-figures based on typical bioreactor control system pricing. The NAICS code is 334516 and PSC code is J070.
Notice text
3 versions
Update #3 · Latest ·
Amendment #002, dated September 26, 2023.
See attached amended RFQ, with changes in yellow highlight. All other RFQ provisions remain the same. The due date has been changed to 9:00 am EDT on Wednesday, September 27, 2023.
This notice is a combined synopsis/solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 “Streamlined Procedures for Evaluation and Solicitation for Commercial Items,” as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested. The Solicitation number is RFQ-NIAID-23-2177803 and the solicitation is issued as a Request for Quotes (RFQ).
The purpose of the acquisition is to procure a mammalian bioreactor control system for the Vaccine Production Program (VPP)/Vaccine Research Center (VRC).
The Vaccine Production Program (VPP) is the development arm of the Vaccine Research Center. The mission of the VRC is to create and develop potentially lifesaving vaccines for HIV, Ebola, Zika, and other known pathogens and get these potentially lifesaving products into the clinic.
Update #2 ·
Amendment #001, dated September 21, 2023.
See attached amended RFQ, with changes in yellow highlight. All other RFQ provisions, including the due date of quotes, remain the same.
This notice is a combined synopsis/solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 “Streamlined Procedures for Evaluation and Solicitation for Commercial Items,” as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested. The Solicitation number is RFQ-NIAID-23-2177803 and the solicitation is issued as a Request for Quotes (RFQ).
The purpose of the acquisition is to procure a mammalian bioreactor control system for the Vaccine Production Program (VPP)/Vaccine Research Center (VRC).
The Vaccine Production Program (VPP) is the development arm of the Vaccine Research Center. The mission of the VRC is to create and develop potentially lifesaving vaccines for HIV, Ebola, Zika, and other known pathogens and get these potentially lifesaving products into the clinic.
Update #1 ·
This notice is a combined synopsis/solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 “Streamlined Procedures for Evaluation and Solicitation for Commercial Items,” as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested. The Solicitation number is RFQ-NIAID-23-2177803 and the solicitation is issued as a Request for Quotes (RFQ).
The purpose of the acquisition is to procure a mammalian bioreactor control system for the Vaccine Production Program (VPP)/Vaccine Research Center (VRC).
The Vaccine Production Program (VPP) is the development arm of the Vaccine Research Center. The mission of the VRC is to create and develop potentially lifesaving vaccines for HIV, Ebola, Zika, and other known pathogens and get these potentially lifesaving products into the clinic.
Files
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity